AGM/EGM5 Jun 2026, 05:51 pm
Novyra Pharmachem (Bansisons Tea) Files Annual Report 2025-26
AI Summary
Novyra Pharmachem Limited, formerly Bansisons Tea Industries Ltd, has filed its 39th Annual Report for the financial year 2025-2026. The report, in compliance with SEBI regulations, has been sent to shareholders and uploaded to the company's website. The filing also includes the notice for the 39th Annual General Meeting (AGM) scheduled for June 25, 2026, where audited financial statements and the re-appointment of a director will be considered.
Key Highlights
- Annual Report for FY 2025-26 filed.
- Company name changed from Bansisons Tea Industries Ltd.
- 39th AGM scheduled for June 25, 2026.
- Audited financial statements to be adopted at AGM.
- Director Sandeep Agarwal up for re-appointment.
Price Impact
More from BANSTEA